Juq-565 Guide

Is JUQ-565 a:

What is JUQ-565?

Abstract

JUQ‑565 is a recently discovered heterocyclic scaffold (C₁₈H₁₆N₄O₂) identified through a high‑throughput phenotypic screen targeting the phosphoinositide‑3‑kinase (PI3K)–Akt signaling axis in aggressive breast cancer models. Here we present a comprehensive pre‑clinical evaluation of JU‑565, covering synthetic route optimization, in‑vitro pharmacology, structure‑activity relationship (SAR) expansion, and in‑vivo efficacy in orthotopic xenograft models of triple‑negative breast cancer (TNBC). JUQ‑565 demonstrates sub‑nanomolar inhibition of PI3Kα (IC₅₀ = 0.42 nM) with >10,000‑fold selectivity over PI3Kβ/γ/δ, robust downstream Akt de‑phosphorylation, and potent antiproliferative activity (GI₅₀ = 8 nM) across a panel of TNBC cell lines. Pharmacokinetic profiling reveals high oral bioavailability (F = 62 %) and favorable tissue distribution, achieving therapeutic concentrations (> 10× IC₅₀) in tumor tissue for > 12 h after a single dose. In orthotopic mouse models, once‑daily oral dosing (30 mg kg⁻¹) resulted in a 78 % tumor growth inhibition (TGI) without overt toxicity. Mechanistic studies indicate that JUQ‑565 also sensitizes TNBC cells to DNA‑damage–inducing agents (e.g., carboplatin) through inhibition of Akt‑mediated DNA repair pathways. Together, these data position JUQ‑565 as a promising clinical candidate for PI3K‑driven malignancies, especially TNBC, and provide a blueprint for its further development. JUQ-565

Jira/Ticketing Systems: Is this a specific issue key for a project you are working on? If so, could you share the title or description of the task?

Speculation and Potential Impact

Without concrete details, speculation abounds. If JUQ-565 relates to a medical or biotechnological advancement, it could hold significant promise for addressing current health challenges. In technology, it might symbolize a leap forward in computing, communication, or sustainable energy. Is JUQ-565 a: What is JUQ-565

Internal Product Codes: Does this refer to a product model (like a spare part or electronics component) that you need a manual or product description for? How I can help Once you clarify the context, I can partner with you to: Draft documentation or a status report for a Jira ticket. Summarize the key points of the specific media file.

Keywords: JUQ‑565, PI3Kα inhibitor, triple‑negative breast cancer, targeted therapy, structure‑activity relationship, oral bioavailability triple‑negative breast cancer

“I have a ship that remembers how to fly and a debt to settle,” Mara replied.

Conclusion